Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Adjuvant chemotherapy for non-small-cell lung cancer: a fading effect?

× No keyword cloud information.

6 in total

1. Maintained sensitivity to EGFR tyrosine kinase inhibitors in EGFR-mutant lung cancer recurring after adjuvant erlotinib or gefitinib.

Authors: Geoffrey R Oxnard; Yelena Y Janjigian; Maria E Arcila; Camelia S Sima; Samantha L Kass; Gregory J Riely; William Pao; Mark G Kris; Marc Ladanyi; Christopher G Azzoli; Vincent A Miller
Journal: Clin Cancer Res Date: 2011-08-10 Impact factor: 12.531

2. Efficacy of Platinum-Based Adjuvant Chemotherapy on Prognosis of Pathological Stage II/III Lung Adenocarcinoma based on EGFR Mutation Status: A Propensity Score Matching Analysis.

Authors: Tetsuya Isaka; Hiroyuki Ito; Haruhiko Nakayama; Tomoyuki Yokose; Kayoko Katayama; Kouzo Yamada; Munetaka Masuda
Journal: Mol Diagn Ther Date: 2019-10 Impact factor: 4.074

3. HDGF and ADAM9 are novel molecular staging biomarkers, prognostic biomarkers and predictive biomarkers for adjuvant chemotherapy in surgically resected stage I non-small cell lung cancer.

Authors: Jun Zhang; Ning Chen; Juan Qi; Baosen Zhou; Xueshan Qiu
Journal: J Cancer Res Clin Oncol Date: 2014-04-27 Impact factor: 4.553

4. Randomized phase III trial of vinorelbine plus cisplatin compared with observation in completely resected stage IB and II non-small-cell lung cancer: updated survival analysis of JBR-10.

Authors: Charles A Butts; Keyue Ding; Lesley Seymour; Philip Twumasi-Ankrah; Barbara Graham; David Gandara; David H Johnson; Kenneth A Kesler; Mark Green; Mark Vincent; Yvon Cormier; Glenwood Goss; Brian Findlay; Michael Johnston; Ming-Sound Tsao; Frances A Shepherd
Journal: J Clin Oncol Date: 2009-11-23 Impact factor: 44.544

Review 5. Adjuvant chemotherapy for resected non-small-cell lung cancer: future perspectives for clinical research.

Authors: Maria Bonomi; Sara Pilotto; Michele Milella; Francesco Massari; Sara Cingarlini; Matteo Brunelli; Marco Chilosi; Giampaolo Tortora; Emilio Bria
Journal: J Exp Clin Cancer Res Date: 2011-12-29

6. High expression of a disintegrin and metalloproteinase-9 predicts a shortened survival time in completely resected stage I non-small cell lung cancer.

Authors: Jun Zhang; Juan Qi; Ning Chen; Weineng Fu; Baosen Zhou; Anguang He
Journal: Oncol Lett Date: 2013-02-22 Impact factor: 2.967

6 in total